Brief

Fed. Circ. Agrees To Speed Up Args In COVID Vax Patent Case

By Elliot Weld · August 24, 2026, 6:15 PM EDT

The Federal Circuit on Monday agreed to accelerate the schedule in a COVID-19 vaccine patent dispute between Moderna and Arbutus Biopharma Corp. by holding arguments in November....

To view the full article, register now.

Documents

Case Information

Case Title

Arbutus Biopharma Corporation v. Moderna, Inc.

Case Number

26-1581

Court

Appellate - Federal Circuit

Nature of Suit

830 Patent Infringement (Fed. Qst.)

Date Filed

March 30, 2026